Latest news
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial - Applied Clinical Trials OnlineApplied Clinical Trials Online · Thu, 06 Aug 2026 13:54:48 GMTPharma Pulse: AstraZeneca-BMS Speculation Cools, Drones Land in Pharmacy, Agentic AI Hits 3PL - Pharmaceutical CommercePharmaceutical Commerce · Thu, 06 Aug 2026 13:01:55 GMTEXCLUSIVE: Council denies senior officer suspensions amid chief executive exit row - The MJThe MJ · Thu, 06 Aug 2026 11:55:54 GMTAstraZeneca shares rise as fresh reports deny mega-merger talks with US rival - This is MoneyThis is Money · Wed, 05 Aug 2026 21:01:02 GMTSource Denies AstraZeneca-Bristol Myers Merger Talks | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 19:02:42 GMTAstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’ - StocktwitsStocktwits · Wed, 05 Aug 2026 16:17:00 GMTAstraZeneca’s reported US merger talks denied by ‘senior source’ - The TimesThe Times · Wed, 05 Aug 2026 15:37:07 GMTSenior Source Denies AstraZeneca and Bristol Myers Deal Talks : Report - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 14:52:36 GMT